<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1657611</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2025.1657611</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>To reconnect or not reconnect distal Purkinje fibers, that is the question when modeling the Purkinje fiber network</article-title>
<alt-title alt-title-type="left-running-head">Bayer et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2025.1657611">10.3389/fphys.2025.1657611</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bayer</surname>
<given-names>Jason D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/303917/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gillette</surname>
<given-names>Karli</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/612073/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coronel</surname>
<given-names>Ruben</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/9098/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Plank</surname>
<given-names>Gernot</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/24950/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vigmond</surname>
<given-names>Edward J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/24932/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Electrophysiology and Heart Modeling Institute</institution>, <institution>IHU Liryc</institution>, <institution>Fondation Bordeaux Universit&#xe9;</institution>, <addr-line>Pessac-Bordeaux</addr-line>, <country>France</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institut de Math&#xe9;matiques de Bordeaux</institution>, <institution>UMR5251</institution>, <institution>University of Bordeaux</institution>, <addr-line>Bordeaux</addr-line>, <country>France</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Scientific Computing and Imaging Institute</institution>, <institution>University of Utah</institution>, <addr-line>Salt Lake City</addr-line>, <addr-line>UT</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Biomedical Engineering</institution>, <institution>University of Utah</institution>, <addr-line>Salt Lake City</addr-line>, <addr-line>UT</addr-line>, <country>United States</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Biophysics</institution>, <institution>Medical University of Graz</institution>, <addr-line>Graz</addr-line>, <country>Austria</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Experimental Cardiology</institution>, <institution>Amsterdam University Medical Centers, Location AMC</institution>, <addr-line>Amsterdam</addr-line>, <country>Netherlands</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/29782/overview">Bum-Rak Choi</ext-link>, Brown University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1425098/overview">Roel Meiburg</ext-link>, University of Eindhoven, Netherlands</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2988436/overview">Benito Baldauf</ext-link>, Hochschule Bremerhaven, Germany</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jason D. Bayer, <email>jason.bayer@ihu-liryc.fr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1657611</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>07</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Bayer, Gillette, Coronel, Plank and Vigmond.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Bayer, Gillette, Coronel, Plank and Vigmond</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background and aims</title>
<p>Multiple rule-based approaches exist to model the structure of the His-Purkinje system (HPS). While some approaches reconnect Purkinje fibers in the Purkinje fiber network, others do not. The aim of this study was to determine the impact of distal Purkinje fiber reconnections on anterograde activation, retrograde activation, and reentrant arrhythmias.</p>
</sec>
<sec>
<title>Methods</title>
<p>In a human biventricular model with or without distal Purkinje fiber reconnections, normal sinus rhythm was simulated by His bundle pacing (anterograde activation), followed by an S1S2 protocol applied to the right ventricular apex (retrograde activation). Activation times in the myocardium and HPS were compared for both anterograde and retrograde HPS activation. Arrhythmia vulnerability windows and duration were determined by identifying the S1S2 coupling intervals that induced a reentry of at least two full rotations. Arrhythmia maintenance was further studied by inducing reentry with 4 Hz line pacing applied to the left ventricular epicardial surface. Reentry duration for each protocol was determined over a 20 s window. The S1S2 and line pacing protocols were repeated in the biventricular model without an HPS.</p>
</sec>
<sec>
<title>Results</title>
<p>Anterograde activation times and arrhythmia initiation vulnerability windows were mostly unaltered when removing distal Purkinje fiber reconnections. However, retrograde activation times were 18% longer in the HPS and 8% longer in the myocardium when removing distal Purkinje fiber reconnections. Reentrant arrhythmias from the S1S2 protocol and rapid line pacing lasted longer for the model with (11.2 and &#x3e;20 s) versus without (3.2 and 8.2 s) distal Purkinje fiber reconnections. The S1S2 protocol did not induce reentrant arrhythmias in the human ventricles model without an HPS, and reentry induced with 4 Hz line pacing lasted only 3.6 s.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Retrograde activation times increased and the duration of reentrant arrhythmias shortened in the absence of Purkinje fiber reconnections in the Purkinje fiber network. This could be an important structural HPS property to incorporate into computational heart models when investigating retrograde activation and/or reentrant arrhythmias. Modifying the structure of the Purkinje fiber network to remove Purkinje fiber reconnections in patients with life threatening ventricular arrhythmia might be antiarrhythmic.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Purkinje network</kwd>
<kwd>conduction system</kwd>
<kwd>modeling</kwd>
<kwd>simulation</kwd>
<kwd>retrograde activation</kwd>
<kwd>anterograde activation</kwd>
<kwd>arrhythmia</kwd>
</kwd-group>
<contract-num rid="cn001">ANR-10-IAHU-04</contract-num>
<contract-num rid="cn002">A0080310517</contract-num>
<contract-num rid="cn003">10.55776/I6540 10.55776/ESP592</contract-num>
<contract-sponsor id="cn001">Agence Nationale de la Recherche<named-content content-type="fundref-id">10.13039/501100001665</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Grand &#xc9;quipement National De Calcul Intensif<named-content content-type="fundref-id">10.13039/501100010190</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Austrian Science Fund<named-content content-type="fundref-id">10.13039/501100002428</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cardiac Electrophysiology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The His-Purkinje system (HPS) is the ventricular component of the cardiac conduction system. It is composed of the His bundle with major fascicles that bifurcate into left and right bundle branches. At the distal regions of each bundle branch is the Purkinje fiber network, which is a complex structure of Purkinje fibers that electrically couples to the myocardium through Purkinje-Muscular Junctions (PMJs).</p>
<p>In the original description of the Purkinje fiber network by Tawara et al. (<xref ref-type="bibr" rid="B36">Tawara, 1906</xref>), it was shown to have Purkinje fibers that branch (bifurcate) and reconnect (converge) within the network. This was later confirmed by India ink injection, transparent specimens, and computed tomography (<xref ref-type="bibr" rid="B13">De Almeida et al., 2015</xref>). During the developmental stages of the heart, the expression of Nkx2-5 in the myocardium promotes this meshing of the Purkinje fibers into the Purkinje fiber network (<xref ref-type="bibr" rid="B31">Park and Fishman, 2017</xref>).</p>
<p>In computer simulations of the cardiac conduction system (<xref ref-type="bibr" rid="B34">Stephenson et al., 2017</xref>), it may be important to accurately model this mesh structure of the Purkinje fiber network within the HPS. In particular, it may play a critical role in the generation of activation patterns during normal sinus rhythm, ventricular pacing, and/or reentrant arrhythmias (<xref ref-type="bibr" rid="B14">Durrer et al., 1970</xref>). Unfortunately, it is difficult to model the complex structure of the HPS in its entirety in three dimensions from imaging alone (<xref ref-type="bibr" rid="B32">Peirlinck et al., 2021</xref>). Consequently, it is commonly reconstructed in human ventricular models using rule-based approaches (<xref ref-type="bibr" rid="B21">Liu and Cherry, 2015</xref>; <xref ref-type="bibr" rid="B39">Vigmond and Clements, 2007</xref>; <xref ref-type="bibr" rid="B19">Ijiri et al., 2008</xref>; <xref ref-type="bibr" rid="B1">Al-Nashash and Lvov, 1997</xref>; <xref ref-type="bibr" rid="B3">Atkinson et al., 2011</xref>).</p>
<p>Rule-based approaches for generating the HPS structure can differ noticeably in the Purkinje fiber network. Specifically, some rule-based approaches develop a mesh structure for the Purkinje fiber network by reconnecting distal Purkinje fibers (<xref ref-type="bibr" rid="B15">Gillette et al., 2021</xref>; <xref ref-type="bibr" rid="B7">Behradfar et al., 2014</xref>), while others have a tree structure without reconnecting distal Purkinje fibers (<xref ref-type="bibr" rid="B12">Costabal et al., 2016</xref>; <xref ref-type="bibr" rid="B2">&#xc1;lvarez-Barrientos et al., 2025</xref>). In other words, the latter approach develops an HPS with unique pathways from the His bundle to the PMJs with only branching of Purkinje fibers. The impact of this difference on anterograde activation, retrograde activation, and reentrant arrhythmia initiation/maintenance is unknown. We hypothesize that modeling the Purkinje fiber network with reconnecting Purkinje fibers facilitates simulating activation times and reentrant behavior observed in patients.</p>
<p>The main objective of this study was to determine the impact of distal Purkinje fiber reconnections on anterograde activation, retrograde activation, and reentrant arrhythmia initiation/maintenance. To accomplish this, we utilized an established computer model of the human ventricles including an HPS (<xref ref-type="bibr" rid="B5">Bayer et al., 2022</xref>), and performed simulations in this model with the same major fascicles and PMJs either with or without reconnections of Purkinje fibers in the Purkinje fiber network. This computational study demonstrates that distal Purkinje connections may play an important role in retrograde activation and arrhythmia maintenance, but not anterograde activation.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec id="s2-1">
<title>Human biventricular model</title>
<p>The electrical activation of ventricular myocardium coupled to the HPS was investigated using an established computer model of the human ventricular conduction system (<xref ref-type="bibr" rid="B5">Bayer et al., 2022</xref>). The full details on the geometry and electrophysiology of the non-failing human ventricles can be found in (<xref ref-type="bibr" rid="B4">Bayer et al., 2016</xref>). The full details on the structure and electrophysiology of the HPS can be found in <xref ref-type="bibr" rid="B7">Behradfar et al. (2014)</xref>, <xref ref-type="bibr" rid="B5">Bayer et al. (2022)</xref>. In short, the parameters governing cellular and tissue electrophysiology in this anatomically accurate human model of the ventricular conduction system were fit to experimental and clinical data in order to reproduce physiologic depolarization and repolarization patterns that generate the human ECG (<xref ref-type="bibr" rid="B14">Durrer et al., 1970</xref>). Specifically, the human biventricular model includes transmural and apicobasal heterogeneity in cellular coupling, calcium handling, and ionic channel currents that generate the physiological depolarization and repolarization patterns intrinsic to human ventricular myocardium. These properties were essential to include since they can impact electrical conduction and arrhythmogenesis in the human heart (<xref ref-type="bibr" rid="B18">Han et al., 2021</xref>).</p>
<p>To introduce an arrhythmic substrate into this otherwise healthy heart model, the maximal conductance of the slow delayed rectifier potassium current (G<sub>Ks</sub>) in the HPS was decreased from the value of 0.98 pS/pF as in <xref ref-type="bibr" rid="B40">Walton et al. (2014)</xref> to its default ventricular myocyte value of 0.392 pS/pF (<xref ref-type="bibr" rid="B37">Tusscher et al., 2004</xref>). The G<sub>Ks</sub> parameter was chosen since it directly influences APD in the model and has been linked to ventricular arrhythmias (<xref ref-type="bibr" rid="B38">Varshneya et al., 2018</xref>). Importantly, the APD generated from this modification to G<sub>Ks</sub> (maximum of 371 ms) was within the physiological data range reported for Purkinje fibers of non-diseased human hearts (<xref ref-type="bibr" rid="B28">Nagy et al., 2015</xref>). With this modification, at normal sinus rhythm rates action potential duration in the HPS is longer than in the myocardium on average by 56 ms across all PMJs in the model. This promotes unidirectional conduction block at short stimulus coupling intervals during the S1S2 programmed stimulation protocol described below. To prevent arrhythmia dynamics from being dependent on variations in PMJ density (<xref ref-type="bibr" rid="B7">Behradfar et al., 2014</xref>), the PMJ density of the HPS in the myocardium was fixed to 15 PMJs per cm<sup>3</sup> with a junctional resistance of 100 k&#x3a9;.</p>
</sec>
<sec id="s2-2">
<title>HPS structure with or without distal Purkinje fiber reconnections</title>
<p>The structure of the HPS in the biventricular model was modified to exclude reconnections between Purkinje fibers within the Purkinje network of the left and right bundle branches (<xref ref-type="fig" rid="F1">Figure 1</xref>). Specially, cross-bridging fibers between the major ascending fibers were disconnected to convert the meshed HPS structure to a tree structure. At each reunification point with two parent nodes, i.e., where two parent cables connected to one child, the second parent cable was removed up to the point where it originated at a bifurcation. Thus, no PMJs were left unconnected to a parent branch after these branch removals, while the major fascicles and bundle branches remained intact. As a result, there were two test cases to study anterograde and retrograde activation. The first test case was the human ventricles model with an HPS that had reconnected Purkinje fibers within the Purkinje fiber network (M<sub>rHPS</sub>, <xref ref-type="fig" rid="F1">Figure 1A</xref>), and the second was the human ventricles with the same HPS but with disconnected Purkinje fibers within the Purkinje fiber network (M<sub>dHPS</sub>, <xref ref-type="fig" rid="F1">Figure 1B</xref>). A third test case was used to investigate how the HPS contributes to reentrant arrhythmia initiation and/or maintenance. This case was the same human ventricles model as used for the other two cases, but with the HPS removed (M<sub>noHPS</sub>, <xref ref-type="fig" rid="F1">Figure 1C</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The three model cases showing the ventricular myocardium with reconnected distal Purkinje fibers <bold>(A)</bold>, disconnected distal Purkinje fibers <bold>(B)</bold>, and without the HPS <bold>(C)</bold>. Black boxes were placed in the RV of each model to zoom in on the Purkinje fiber structure to show the presence or absence of distal Purkinje fiber reconnections. Red stars in the inset of <bold>(B)</bold> indicates where distal Purkinje fiber reconnections were disconnected (removed) from the inset in <bold>(A)</bold>.</p>
</caption>
<graphic xlink:href="fphys-16-1657611-g001.tif">
<alt-text content-type="machine-generated">Three panels illustrate heart models and fiber structures. Panel A shows the heart with labeled ventricles (RV, LV) and a dense network of Purkinje fibers, highlighted in pink. Panel B depicts a similar heart model with labeled myocardium and Purkinje fibers marked with red asterisks. Panel C shows an unlabeled heart model without Purkinje fibers. Each panel includes a close-up of the fiber structures.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-3">
<title>Anterograde activation</title>
<p>The His bundle was paced at a cycle length (CL) of 750 ms for 10 cycles. Activation times (ATs) were computed at each node of the myocardial and HPS meshes for the last cycle of pacing as the moment when the action potential upstroke exceeded the voltage threshold of &#x2212;10 mV. Differences in the activation patterns between the two test cases in <xref ref-type="fig" rid="F1">Figure 1</xref> were quantified using the method of Han et al. (<xref ref-type="bibr" rid="B17">Han et al., 2012</xref>). Using this approach, the relative difference (RD), root mean square difference (RMSD) and correlation coefficient (CC) were computed for the comparisons M<sub>dHPS</sub> versus M<sub>rHPS</sub> and M<sub>noHPS</sub> versus M<sub>rHPS</sub>.</p>
</sec>
<sec id="s2-4">
<title>Retrograde activation</title>
<p>Following His pacing, the right ventricular endocardial apex was paced (S1) at a CL of 600 ms for 10 cycles from a spherical region with a diameter of 1.5 mm. This stimulus diameter was chosen to mimic a standard 5F catheter size used for clinical pacing studies. Activation times (ATs) were computed and compared in the same manner as previously described for anterograde conduction. Note, the CL of 600 ms was chosen since it is a commonly used CL for programmed electrical stimulation in cardiac electrophysiology laboratories. This CL is also within the range used to investigate retrograde activation (<xref ref-type="bibr" rid="B35">Sung et al., 1981</xref>). Since this CL mimics a heart rate slightly higher than normal resting heart rates (100 bpm vs. 60&#x2013;90 bpm), it prevents sinus rhythm activation originating from the atria from interfering with S1 capture. Since APD restitution of the ventricular myocardium in the model does not steepen until S1 CL &#x3c; 500 ms (120 bpm) (<xref ref-type="bibr" rid="B4">Bayer et al., 2016</xref>), retrograde activation patterns were not dependent on our choice of S1 CL &#x3e; 500 ms.</p>
</sec>
<sec id="s2-5">
<title>Arrhythmia initiation</title>
<p>Following S1 pacing, premature S2 stimuli were applied at the same RV pacing site with a CI beginning at 400 ms, which mimics programmed electrical stimulation used to induce ventricular arrhythmias in cardiac electrophysiology laboratories. The S1S2 CI was then gradually reduced by decrements of 10 ms until a loss of stimulus capture. All pacing stimuli were administered with a 2 ms duration at a strength of twice the diastolic threshold. The diastolic stimulus threshold was determined for each new set of model parameters. Following each S2 stimulus, the transmembrane voltage maps of the ventricular myocardium and HPS were inspected for unidirectional conduction block and reentry that lasted for more than 2 full rotations. In other words, reentry was identified when a point in the HPS or ventricles was activated more than once following the S2. The vulnerable window of reentry was recorded by identifying the first and last S2 coupling intervals that generated reentry.</p>
</sec>
<sec id="s2-6">
<title>Arrhythmia maintenance</title>
<p>In addition to studying arrhythmia maintenance following reentries from the S1S2 protocol, reentry was induced with rapid line pacing using the protocol from our previous computational and animal studies (<xref ref-type="bibr" rid="B26">Moreno et al., 2022</xref>; <xref ref-type="bibr" rid="B25">Moreno et al., 2019</xref>; <xref ref-type="bibr" rid="B6">Bayer et al., 2024</xref>). This protocol consistently induces the same reentry in each of the three models to unbiasedly study how the arrhythmic substrate maintains the induced arrhythmia. In short, pacing was administered from an apicobasal line electrode 2 mm in diameter on the left ventricular epicardium by stimulating the entire line at 8x the diastolic stimulation threshold with a pacing CL of 400 ms for 10 cycles. The 8x capture threshold strength ensured homogeneous activation across the entire line. Subsequently, reentry was induced with rapid pacing from the same line electrode with a pacing CL of 250 ms for 10 cycles at 8x the diastolic stimulation threshold. Reentry was verified by visual inspection of the transmembrane voltage maps in the HPS and/or myocardium. The duration of this reentry, as well as the reentry induced for the longest S2 coupling interval from the S1S2 protocol, was recorded over a 20 s window until the reentry self-terminated or the end of the arrhythmia observation window was reached.</p>
</sec>
<sec id="s2-7">
<title>Simulation platform</title>
<p>Monodomain simulations were performed using the cardiac electrophysiology simulator CARP-EP (numericor.at) running in parallel on 512 cores. For this study, simulations for the preconditioning normal sinus rhythm protocol, S1S2 protocol, and rapid line pacing protocol were performed for the 2 cases with different HPS structures and the case without an HPS. These simulations had a computational cost of 34,560 CPU hours on 512 cores of the high-performance analytics and computing platform IRENE (Joliot-Curie) at the TGCC supercomputing center. All simulations used a time step of 20 &#x3bc;s, and their results were visualized using the software Meshalyzer (<ext-link ext-link-type="uri" xlink:href="https://git.opencarp.org/openCARP/meshalyzer">https://git.opencarp.org/openCARP/meshalyzer</ext-link>). Stimuli for all protocols were administered by transmembrane current injection with diastolic stimulation thresholds obtained by increasing the stimulus strength in increments of 1 &#x3bc;A/cm (starting from zero) until action potential propagation was initiated in the myocardium from the stimulus site.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Anterograde activation</title>
<p>For each test case in <xref ref-type="fig" rid="F1">Figure 1</xref>, activation times were computed at the end of the normal sinus rhythm protocol to identify differences in anterograde conduction in the ventricular myocardium and HPS. <xref ref-type="fig" rid="F2">Figure 2</xref> shows the total activation times in the HPS and the myocardium for the models with distal Purkinje fiber reconnections (M<sub>rHPS</sub>, <xref ref-type="fig" rid="F2">Figure 2A</xref>) and without distal Purkinje fiber reconnections (M<sub>dHPS</sub>, <xref ref-type="fig" rid="F2">Figure 2B</xref>). Minor differences were observed in the isolines between the activation maps in the ventricular myocardium between cases M<sub>rHPS</sub> and M<sub>dHPS</sub> (compare <xref ref-type="fig" rid="F2">Figure 2A</xref> with <xref ref-type="fig" rid="F2">Figure 2C</xref>). To quantify these differences, the RD, RMSD, and CC were computed for the comparison between the M<sub>dHPS</sub> and M<sub>rHPS</sub> models (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The two model cases with an HPN showing anterograde activation in transmembrane voltage maps of the HPS and myocardium either with reconnected distal Purkinje fibers <bold>(A)</bold> or disconnected distal Purkinje fibers <bold>(B)</bold> Isoline spacing is 10 ms. Activation times ranged from 21 to 136 ms in the myocardium and 0&#x2013;67 ms in the HPS of <bold>(A)</bold> and 21&#x2013;137 ms in the myocardium and 0&#x2013;70 ms in the HPS of <bold>(B)</bold> The absolute difference in activation times between the two cases is shown in <bold>(C)</bold>.</p>
</caption>
<graphic xlink:href="fphys-16-1657611-g002.tif">
<alt-text content-type="machine-generated">Three-panel image showing ventricular activation times in different conditions. Panel A and B show 3D heart models with contour lines indicating activation times ranging from blue (0 ms) to red (137 ms). Panel C shows the difference in activation times with a dark red and black color scheme. Below each panel, corresponding Purkinje network visuals are displayed, with color mapping matching the activation times.</alt-text>
</graphic>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Comparison of anterograde and retrograde activation times between the models with reconnected distal Purkinje fibers and disconnected distal Purkinje fibers.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center"/>
<th align="center">%&#x7c;&#x2206; in total AT&#x7c;</th>
<th align="center">RD (%)</th>
<th align="center">RMSD (ms)</th>
<th align="center">CC</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="5" align="left">
<italic>Anterograde</italic> <italic>M</italic>
<sub>
<italic>dHPS</italic>
</sub> <italic>vs. M</italic>
<sub>
<italic>rHPS</italic>
</sub>
</td>
</tr>
<tr>
<td align="center">Myocardium</td>
<td align="center">0.87</td>
<td align="center">0.03</td>
<td align="center">1.36 &#xb1; 1.43</td>
<td align="center">0.99</td>
</tr>
<tr>
<td align="center">HPS</td>
<td align="center">4.41</td>
<td align="center">0.08</td>
<td align="center">3.21 &#xb1; 3.26</td>
<td align="center">0.97</td>
</tr>
<tr>
<td colspan="5" align="left">
<italic>Retrograde</italic> <italic>M</italic>
<sub>
<italic>dHPS</italic>
</sub> <italic>vs. M</italic>
<sub>
<italic>rHPS</italic>
</sub>
</td>
</tr>
<tr>
<td align="center">Myocardium</td>
<td align="center">7.86</td>
<td align="center">0.09</td>
<td align="center">7.24 &#xb1; 5.08</td>
<td align="center">0.98</td>
</tr>
<tr>
<td align="center">HPS</td>
<td align="center">18.18</td>
<td align="center">0.20</td>
<td align="center">8.95 &#xb1; 6.12</td>
<td align="center">0.95</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>For the comparison of the M<sub>dHPS</sub> and M<sub>rHPS</sub> models, in the myocardium for the HPS with disconnected distal Purkinje fibers, total activation time increased by only 1 ms, while the absolute change in total AT was less than 1% with the RMSD only slightly larger than a millisecond. In the HPS, these values were larger by only a few milliseconds. The CC values &#x2265; 0.97 showed a very strong linear relationship between the activation patterns for these two test cases. <xref ref-type="fig" rid="F2">Figure 2C</xref> shows the distribution in the absolute difference in activation times between the two models.</p>
<p>The impact of using different G<sub>Ks</sub> values between the default (0.98 pS/pF) and arrhythmogenic (0.392 pS/pF) values on anterograde activation was unnoticeable. For any value within this range differing by 0.1 pS/pF, we did not find changes &#x3e;1 ms to anterograde activation times nor activation patterns. This was due to the CV restitution curves of the HPS and myocardium being flat at the His pacing CL of 750 ms.</p>
</sec>
<sec id="s3-2">
<title>Retrograde activation</title>
<p>For each test case in <xref ref-type="fig" rid="F1">Figure 1</xref>, activation times were computed at the end of S1 pacing to identify differences in the retrograde activation of the ventricular myocardium and HPS. <xref ref-type="fig" rid="F3">Figure 3</xref> shows the total activation times in the HPS and the myocardium for the models M<sub>rHPS</sub> <xref ref-type="fig" rid="F3">Figure 3A</xref> and M<sub>dHPS</sub> (<xref ref-type="fig" rid="F3">Figure 3B</xref>). In contrast to anterograde conduction, differences in the activation maps between <xref ref-type="fig" rid="F3">Figures 3A,B</xref> appeared larger in the ventricular myocardium and HPS. To quantify these differences, the RD, RMSD, and CC were computed in the same manner as for anterograde activation in order to compare between the M<sub>dHPS</sub> and M<sub>rHPS</sub> models (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The two model cases with an HPN showing retrograde activation in transmembrane voltage maps of the HPS and myocardium either with reconnected distal Purkinje fibers <bold>(A)</bold> or disconnected distal Purkinje fibers <bold>(B)</bold>. Isoline spacing is 10 ms. Activation times ranged from 0 to 130 ms in the myocardium and 8&#x2013;80 ms in the HPS of <bold>(A)</bold> and 0&#x2013;141 ms in the myocardium and 8&#x2013;96 ms in the HPS of <bold>(B)</bold>. The absolute difference in activation times between the two cases is shown in <bold>(C)</bold>.</p>
</caption>
<graphic xlink:href="fphys-16-1657611-g003.tif">
<alt-text content-type="machine-generated">Three panels depict heart activation patterns. Panel A: Color map of \(M_{RHPS}\) showing activation times, ranging from red (earliest) to blue (latest). Panel B: Similar map for \(M_{dHPS}\) in the myocardium. Panel C: Difference between \(M_{RHPS}\) and \(M_{dHPS}\), highlighting areas with varied activation times in red to yellow. Corresponding line diagrams of the His-Purkinje system are shown below each map.</alt-text>
</graphic>
</fig>
<p>For the comparison of the M<sub>dHPS</sub> and M<sub>rHPS</sub> models, in the myocardium of M<sub>dHPS</sub> total activation time increased by 11 ms, while the absolute change in total AT was 7.86% with an RMSD of 7.25 ms. In the HPS of M<sub>dHPS</sub> compared to M<sub>rHPS</sub>, the increase in total activation time was larger by 16 ms along with a larger absolute change in total AT of 18.18% and an RMSD of 8.95 ms. The CC values &#x2265; 0.95 still showed a strong linear relationship between the activation patterns for these two test cases. <xref ref-type="fig" rid="F3">Figure 3C</xref> shows the distribution in the absolute difference in activation times between the two models.</p>
<p>The impact of using different G<sub>Ks</sub> values between the default (0.98 pS/pF) and arrhythmogenic (0.392 pS/pF) values on retrograde activation was also unnoticeable. For any value within this range differing by 0.1 pS/pF, we did not find changes &#x3e;1 ms to retrograde activation times nor activation patterns. This was due to the CV restitution curves of the HPS and myocardium being flat at the His pacing CL of 600 ms.</p>
</sec>
<sec id="s3-3">
<title>Arrhythmia initiation</title>
<p>Results for the arrhythmias induced with the S1S2 protocol applied to the RV endocardial apex of the three test models are shown in <xref ref-type="table" rid="T2">Table 2</xref>. Reentry was initiated in M<sub>rHPS</sub> and M<sub>dHPS</sub>, but not M<sub>noHPS</sub>. The vulnerable windows for the test cases M<sub>rHPS</sub> and M<sub>dHPS</sub> were similar (S1S2 coupling intervals from 270 to 320 ms). Within the arrhythmia vulnerability windows for M<sub>rHPS</sub> and M<sub>dHPS</sub>, reentry was induced by unidirectional conduction block that lasted for at least 2 full rotations (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Arrhythmia initiation and maintenance of reentry following the S1S2 and rapid line pacing protocols.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center"/>
<th align="center">M<sub>rHPS</sub>
</th>
<th align="center">M<sub>dHPS</sub>
</th>
<th align="center">M<sub>noHPS</sub>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="4" align="left">
<italic>Initiation</italic>
</td>
</tr>
<tr>
<td align="center">Last S2 capture</td>
<td align="center">260</td>
<td align="center">260</td>
<td align="center">260</td>
</tr>
<tr>
<td align="center">First reentry after S2 (ms)</td>
<td align="center">320</td>
<td align="center">320</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">Last reentry after S2 (ms)</td>
<td align="center">270</td>
<td align="center">270</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td colspan="4" align="left">
<italic>Maintenance</italic>
</td>
</tr>
<tr>
<td align="center">Reentry duration following S2 &#x3d; 320 ms (s)</td>
<td align="center">11.2</td>
<td align="center">3.2</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">Reentry duration following line pacing (s)</td>
<td align="center">&#x3e;20</td>
<td align="center">8.2</td>
<td align="center">3.6</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Reentrant arrhythmias in the model with reconnected distal Purkinje fibers with the S1S2 protocol applied to the endocardial RV apex (top row) and the rapid LV epicardial line pacing protocol (bottom row). The stimulus locations are shown in green in <bold>(A)</bold> and the reentrant arrhythmia in the transmembrane voltage maps (Vm) are shown in <bold>(B)</bold> at two time points during the first 5 s of reentry.</p>
</caption>
<graphic xlink:href="fphys-16-1657611-g004.tif">
<alt-text content-type="machine-generated">Panel A shows a 3D model of the heart with labeled sections: LV (left ventricle) and RV (right ventricle). It illustrates a stimulus application at S1S2 and line pacing for cardiac studies. Panel B depicts two reentry patterns over time at one second and five seconds, with color coding for activation times using a blue to red spectrum from negative ninety to twenty milliseconds.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-4">
<title>Arrhythmia maintenance</title>
<p>Arrhythmia maintenance was quantified as the duration of the reentry that was visible in the myocardium and/or HPS after the administration of rapid line pacing, as well as for reentry following the S1S2 coupling interval of 320 ms. The duration of these arrhythmias can be found in <xref ref-type="table" rid="T2">Table 2</xref>. Note, rapid line pacing initiated reentrant arrhythmias in all three models, with an example shown for M<sub>rHPS</sub> in <xref ref-type="fig" rid="F4">Figure 4</xref>. The reentries in all three models started out as a figure-of-eight reentry from conduction block along the electrode placed along the apicobasal axis of the ventricles. After a few seconds the behavior of the reentry changed with respect to the structure or presence of the HPN. Specifically, these reentries lasted for the entire 20 s observation window in M<sub>rHPS</sub> and less than 9 s in M<sub>dHPS</sub>. Reentry was even shorter in M<sub>noHPS</sub> lasting less than 4 s. Similar results were observed for the S1S2 coupling interval of 320 ms, where reentry duration was 3.2 s for M<sub>dHPS</sub> and the entire 20 s observation period for M<sub>rHPS</sub>.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>This study used a state-of-the-art computational model of the human ventricles and HPS to identify how Purkinje fiber reconnections in the Purkinje fiber network influence anterograde activation, retrograde activation, and reentrant arrhythmias. This <italic>in silico</italic> study demonstrates that retrograde activation patterns and arrhythmia maintenance can be impacted by distal Purkinje fiber reconnections, while antegrade activation patterns and arrhythmia initiation are not. In the model with disconnected distal Purkinje fibers, the total retrograde activation time increased by 8% in the myocardium and 18% in the HPS compared to the model with reconnected distal Purkinje fibers. Reentrant arrhythmias from the S1S2 protocol and rapid line pacing lasted longer in the model with reconnected (11.2 and &#x3e;20 s) versus disconnected (3.2 and 8.2 s) distal Purkinje fibers.</p>
<sec id="s4-1">
<title>The dependence of anterograde conduction on Purkinje fiber network structure was weak in the model</title>
<p>Numerous studies have implemented the rule-based approaches mentioned in the introduction (<xref ref-type="bibr" rid="B21">Liu and Cherry, 2015</xref>; <xref ref-type="bibr" rid="B39">Vigmond and Clements, 2007</xref>; <xref ref-type="bibr" rid="B19">Ijiri et al., 2008</xref>) into digital twinning pipelines (<xref ref-type="bibr" rid="B15">Gillette et al., 2021</xref>; <xref ref-type="bibr" rid="B7">Behradfar et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Costabal et al., 2016</xref>). These pipelines aim to reproduce patient-specific activation patterns and ECGs during normal sinus rhythm. Regardless of the choice of the rule-based algorithm to generate HPS structure, they have shown success for reproducing physiological activation patterns underlying the ECG during normal sinus rhythm.</p>
<p>The universal success of these approaches indicates that reproducing the detailed structure of the Purkinje network may not be critical for generating patient activation patterns and QRS durations during normal sinus rhythm. In other words, changing the structure of the Purkinje network should not significantly impact activation patterns on the endocardium of the ventricles as long as the macrostructure of the HPS is modeled appropriately.</p>
<p>
<xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="table" rid="T1">Table 1</xref> of our study show that when removing reconnections in the Purkinje fiber network, the difference in total anterograde activation time without Purkinje fiber network reconnections was only a few milliseconds. Therefore, we concluded that the generation of the initial endocardial activations observed in the human ventricles by <xref ref-type="bibr" rid="B14">Durrer et al. (1970)</xref> is more dependent on the major fascicles of the left and right bundle branches in the model than on the topology of the Purkinje fiber network. Thus, efforts should be focused more on the macrostructure of the left and right bundle branches in the HPS if the only goal is to simulate anterograde activation patterns in the ventricles. Furthermore, this independence on the algorithm used to generate HPS structures for normal sinus rhythm provides users with the flexibility to choose from a wider array of rule-base approaches that best fits their needs. For example, methods that simplify the HPS into a thin fast-conducting endocardial layer are computationally inexpensive and have shown promise for simulating sinus rhythm activation (<xref ref-type="bibr" rid="B29">Okada et al., 2018</xref>). Such approaches might be more practical to employ for studies that require a large number of sinus rhythm simulations to be performed in a large number of heart models.</p>
</sec>
<sec id="s4-2">
<title>The dependence of retrograde activation on Purkinje fiber network structure was stronger in the model</title>
<p>Few studies have investigated how Purkinje fiber network structure impacts retrograde activation patterns and reentrant arrhythmias in intact human ventricles (<xref ref-type="bibr" rid="B5">Bayer et al., 2022</xref>; <xref ref-type="bibr" rid="B6">Bayer et al., 2024</xref>). Our <italic>in silico</italic> study demonstrates that retrograde activation from ventricular pacing, ectopic foci, or reentrant arrhythmias can differ from anterograde activation depending on the structure of the Purkinje fiber network. This is due to electrical activation from the myocardium being able to re-enter the HPS at multiple locations at different times.</p>
<p>Our study suggests that reconnected Purkinje fibers in the Purkinje fiber network can be an essential feature to model when investigating retrograde activation in ventricles during ventricular pacing and reentrant arrhythmias. In models with disconnected distal Purkinje fibers, we expect that corroborating simulation results with animal and/or clinical data will be more challenging. Thus, drawing conclusions on activation patterns simulated during ventricular pacing and reentrant behaviors observed in models without distal Purkinje fiber reconnections should be done with extreme caution.</p>
<p>Imaging data supports the need for modeling a Purkinje fiber network with Purkinje fiber reconnections (<xref ref-type="bibr" rid="B34">Stephenson et al., 2017</xref>; <xref ref-type="bibr" rid="B30">Ono et al., 2009</xref>; <xref ref-type="bibr" rid="B9">Cha et al., 2020</xref>). From these studies, it is clear that distal Purkinje fibers reconnect. Furthermore, the Purkinje network is generated from a contiguous endocardial layer of specialized myocardium during the early stages of development (<xref ref-type="bibr" rid="B33">Sedmera and Gourdie, 2014</xref>). Therefore, the branching and reconnection of distal Purkinje fibers is to be expected. Due to the impact of the Purkinje fiber network structure on retrograde activation maps and arrhythmia behavior, future studies should focus on modeling more accurately both the macrostructure and microstructure of the HPS, as well as making rule-based HPS algorithms more flexible to include new rules for HPS structure as imaging studies evolve.</p>
</sec>
<sec id="s4-3">
<title>Arrhythmia initiation and maintenance</title>
<p>Our <italic>in silico</italic> study suggests that arrhythmia initiation is less dependent on the structure of the Purkinje network than arrhythmia maintenance. This makes sense since the initiation of arrhythmias using the protocols from this study relies heavily on the presence of repolarization heterogeneity for induction. Specifically, the S1S2 protocol relies on the action potential duration heterogeneity across the PMJs to generate unidirectional conduction block and reentry (<xref ref-type="bibr" rid="B7">Behradfar et al., 2014</xref>; <xref ref-type="bibr" rid="B24">Martinez et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Haissaguerre et al., 2016</xref>). For the rapid line pacing protocol, it relies on the apicobasal action potential duration heterogeneity in the ventricular myocardium to generate unidirectional conduction block and reentry (<xref ref-type="bibr" rid="B4">Bayer et al., 2016</xref>). Therefore, it is not surprising that distal Purkinje fiber reconnections had little effect on arrhythmia initiation, i.e., the first few rotations of a reentry generated from unidirectional conduction block.</p>
<p>As the reentrant arrhythmia persisted, the role of both anterograde and retrograde conduction within the HPS became important regardless of the arrhythmia initiation protocol that was used (<xref ref-type="fig" rid="F4">Figure 4</xref>; <xref ref-type="table" rid="T2">Table 2</xref>). A previous study by our group showed that defibrillation success using low-energy approaches relies heavily on eliminating reentrant pathways through the HPS (<xref ref-type="bibr" rid="B5">Bayer et al., 2022</xref>). We also showed that rapidly pacing the His bundle helps to eliminate HPS reentrant pathways, where at specific frequencies this caused the reentrant arrhythmia to terminate (<xref ref-type="bibr" rid="B6">Bayer et al., 2024</xref>). Therefore, when there are more Purkinje fiber reconnections within the Purkinje fiber network, the number of possible reentrant pathways in the HPS should also increase to promote the maintenance of reentrant arrhythmias. Future work will investigate the mechanism of specific types and locations of distal Purkinje reconnections regarding these pathways in the HPN.</p>
<p>Further supporting the role of the Purkinje network in lethal ventricular arrhythmias, it has been shown that removing Purkinje activation sites with radiofrequency ablation is anti-arrhythmic (<xref ref-type="bibr" rid="B11">Coronel et al., 2021</xref>). Thus, modifying the structure of the Purkinje fiber network to remove Purkinje fiber reconnections in patients with life threatening ventricular arrhythmia may be antiarrhythmic. This could theoretically be done with gene therapy (<xref ref-type="bibr" rid="B41">Wang et al., 2025</xref>), ablation (<xref ref-type="bibr" rid="B20">Imnadze and Zerm, 2019</xref>), or pacing (<xref ref-type="bibr" rid="B6">Bayer et al., 2024</xref>). Based on our recent findings and this body of work on the role of the Purkinje network in ventricular arrhythmias, further imaging studies should investigate how Purkinje fiber reconnections within the Purkinje fiber network vary between patients, and if patients with more distal Purkinje fiber reconnections are more susceptible to arrhythmias.</p>
<p>The propensity of sustained ventricular arrhythmias in the model with the mesh HPS structure may be explained by the microstructure of the HPS. For example, there could be current source-sink mismatches during retrograde activation of the HPS when thinner Purkinje fibers merge into a single thicker Purkinje fiber. When these current source-sink mismatches become large enough, which would be expected at fast rates of activation, they could lead to unidirectional conduction block and sustained reentry if the surrounding HPS architecture and coupled myocardium provide a suitable pathway to support reentry (<xref ref-type="bibr" rid="B10">Ciaccio et al., 2018</xref>). Since the model with the mesh HPS structure has more interconnections between Purkinje fibers than the tree HPS structure, this may explain its higher propensity towards sustained ventricular reentrant arrhythmias. Future studies are warranted to identify the occurrence and conditions for these current source-sink mismatches to occur in the Purkinje network of the HPS, in addition to determining the specific micro-architectures in the finer branches of the HPS that are able to support sustained reentry. To validate this study, imaging data will be required to verify the existence of these micro-architectural structures.</p>
<p>In addition to HPS microstructure, there is evidence that spatial heterogeneity exists in the repolarization of the HPS which could impact HPS-mediated reentrant arrhythmias. In isolated Purkinje/myocardial tissue preparations from canine and human ventricles, APD prolongs from the His bundle to the distal regions of the Purkinje network, and then shortens again closer to PMJs (<xref ref-type="bibr" rid="B27">Myerburg et al., 1970</xref>). In optical mapping studies using <italic>ex vivo</italic> rabbit hearts (<xref ref-type="bibr" rid="B22">Logantha et al., 2021</xref>), APD is longer near the His bundle than in distal Purkinje fibers. Consequently, this spatial heterogeneity in APD could impact the initiation and/or maintenance of the reentries observed in our human ventricles model with the HPS. To address this issue, future studies are planned with our model to investigate the mechanisms of HPS-mediated reentrant arrhythmias in relation to spatial heterogeneities in the HPS from calcium handling, ion channel currents, and cellular coupling.</p>
</sec>
<sec id="s4-4">
<title>Clinical significance</title>
<p>The findings of this study may have clinical significance to noninvasive therapies for ventricular tachyarrhythmias, such as Sterotactic body radiotherapy (SBRT) (<xref ref-type="bibr" rid="B8">Blanck et al., 2020</xref>). When anti-arrhythmic drugs and radiofrequency ablation fail to terminate and prevent the reoccurrence of ventricular tachyarrhythmias, SBRT is an alternative for permanently removing the arrhythmic substrate. During SBRT the entire myocardium is exposed to doses of radiation in the range of 15&#x2013;40 Gy, which in turn has been shown in rats to increase conduction velocity, shorten action potential duration, and increase the peak of the calcium transient in the ventricular myocardium (<xref ref-type="bibr" rid="B23">Mages et al., 2025</xref>). These changes are antiarrhythmic in cardiac tissue by reducing the wavelength of reentry (APD&#x2a;CV). Furthermore, SBRT is non-selective and likely reduces the APD gradient across the PMJs, which our studies suggest could be antiarrhythmic. Future simulation studies will hopefully provide valuable mechanistic insight into the effectiveness of SBRT for treating lethal ventricular arrhythmias.</p>
</sec>
<sec id="s4-5">
<title>Limitations</title>
<p>Due to the computational expense of performing simulations in the human model of the ventricular conduction system, we only used a single human ventricular geometry and HPS to investigate anterograde activation, retrograde activation, and reentrant arrhythmias. To speed up simulation times and reduce computational costs, using eikonal approaches as done for solving anterograde ventricular activation maps (<xref ref-type="bibr" rid="B15">Gillette et al., 2021</xref>) is not practical for retrograde activation maps and reentry in the HPS. We plan to expand this study to multiple hearts, both healthy and diseased, when new approaches arise that are capable of achieving this feature. Specifically, we till target hearts with fibrosis, scars, and age/sex-related changes in cardiac electrophysiology and geometry. Secondly, we artificially introduced the arrhythmic substrate for S1S2 programmed stimulation to induce reentrant arrhythmias by decreasing G<sub>Ks</sub> in the HPS. For now, we deem this acceptable since little is known regarding the structure and function of the HPS in diseased hearts. When such data becomes available in the future, this study will be expanded to include specific pathological abnormalities in the structure and electrophysiology of the HPS. We will also thoroughly perform a sensitivity analysis of our results to a wider range of GKs values than used for this study. Thirdly, we used a fixed 15 PMJs per cm<sup>3</sup> density in the human ventricles model. According to the study by Behradfar et al. (<xref ref-type="bibr" rid="B7">Behradfar et al., 2014</xref>), increasing PMJ density above this value is not expected to impact arrhythmia dynamics, but reducing it below 13 PMJs per cm<sup>3</sup> could. Thus, future studies are warranted to investigate the impact of lower PMJs densities in the model on the arrhythmia outcome of our study. Fourth, we only performed programmed electrical stimulation using a clinical S1S2 protocol administered to the right ventricular endocardial apex for studying retrograde activation and arrhythmogenesis. It is possible that retrograde activation and arrhythmia initiation/maintenance could be impacted by the pacing location in the ventricles. In future studies we plan to investigate how various cardiac resynchronization therapy setups impact retrograde activation patterns and arrhythmogenesis. Fifth, we assume that the HPS structure at the left and right ventricular apex is continuous with the lower portion of the septum. We also assume that only major fascicles without PMJs exist in the middle to upper sections of the right ventricular septum. This is notably different from other approaches constructing rule-based HPSs for digital twinning purposes (<xref ref-type="bibr" rid="B15">Gillette et al., 2021</xref>). The impact of these differences in HPS structure on retrograde activation and arrhythmogenesis will also be explored in future studies and validated with imaging and electrophysiology data from human hearts when available. Lastly, our simulation study lacked mechano-electric and neural feedback. While it is acknowledged that both can influence activation patterns and arrhythmogenesis in the human ventricles, they were not included in our study at this time in order to keep the computational expenses and complexity of our simulations manageable. When possible and appropriate to do so, they will be included in future studies to help refine the model and provide confidence to the simulation results.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s11">
<title>Conclusion</title>
<p>Retrograde activation times increased and the duration of reentrant arrhythmias shortened in the absence of distal Purkinje fiber reconnections observed in histological and imaging studies. The reconnection of distal Purkinje fibers could be an important structural HPS property to incorporate into computational heart models when investigating retrograde activation and/or reentrant arrhythmias. Modifying the structure of the Purkinje fiber network to remove Purkinje fiber reconnections in patients with life threatening ventricular arrhythmia may be antiarrhythmic.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="author-contributions" id="s6">
<title>Author contributions</title>
<p>JB: Writing &#x2013; review and editing, Writing &#x2013; original draft. KG: Writing &#x2013; review and editing. RC: Writing &#x2013; review and editing. GP: Writing &#x2013; review and editing. EV: Writing &#x2013; original draft, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. We acknowledge the support of GENCI computing resources, allocation A0080310517 utilized at the TGCC supercomputing center. This research was funded by the French National Research Agency grant ANR-10-IAHU-04 (to JB and EV) and the Austrian Science Fund grant 10.55776/ESP592 (to KG) and 10.55776/I6540 (to GP).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="s9">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Nashash</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lvov</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Three-dimensional model for the simulation of the HPS electrogram</article-title>. <source>Biomed. Mater Eng.</source> <volume>7</volume> (<issue>6</issue>), <fpage>401</fpage>&#x2013;<lpage>410</lpage>.<pub-id pub-id-type="pmid">9622108</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xc1;lvarez-Barrientos</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Salinas-Camus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pezzuto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Costabal</surname>
<given-names>F. S.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Probabilistic learning of the purkinje network from the electrocardiogram</article-title>. <source>Med. Image Anal.</source> <volume>101</volume>, <fpage>103460</fpage>. <pub-id pub-id-type="doi">10.1016/j.media.2025.103460</pub-id>
<pub-id pub-id-type="pmid">39884028</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atkinson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Inada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tellez</surname>
<given-names>J. O.</given-names>
</name>
<name>
<surname>Yanni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sleiman</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Anatomical and molecular mapping of the left and right ventricular his-purkinje conduction networks</article-title>. <source>J. Mol. Cell Cardiol.</source> <volume>51</volume> (<issue>5</issue>), <fpage>689</fpage>&#x2013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.05.020</pub-id>
<pub-id pub-id-type="pmid">21741388</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayer</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Lalani</surname>
<given-names>G. G.</given-names>
</name>
<name>
<surname>Vigmond</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Narayan</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Trayanova</surname>
<given-names>N. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Mechanisms linking electrical alternans and clinical ventricular arrhythmia in human heart failure</article-title>. <source>Hear Rhythm</source> <volume>13</volume>, <fpage>1922</fpage>&#x2013;<lpage>1931</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2016.05.017</pub-id>
<pub-id pub-id-type="pmid">27215536</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayer</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Sobota</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ja&#xef;s</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vigmond</surname>
<given-names>E. J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The purkinje network plays a major role in low-energy ventricular defibrillation</article-title>. <source>Comput. Biol. Med.</source> <volume>141</volume>, <fpage>105133</fpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2021.105133</pub-id>
<pub-id pub-id-type="pmid">34954609</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayer</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Sobota</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Ha&#xef;ssaguerre</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vigmond</surname>
<given-names>E. J.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>A his bundle pacing protocol for suppressing ventricular arrhythmia maintenance and improving defibrillation efficacy</article-title>. <source>Comput. Methods Programs Biomed.</source> <volume>253</volume>, <fpage>108239</fpage>. <pub-id pub-id-type="doi">10.1016/j.cmpb.2024.108239</pub-id>
<pub-id pub-id-type="pmid">38823116</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behradfar</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nygren</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vigmond</surname>
<given-names>E. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The role of purkinje-myocardial coupling during ventricular arrhythmia: a modeling study</article-title>. <source>PLoS One</source> <volume>9</volume> (<issue>2</issue>), <fpage>e88000</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0088000</pub-id>
<pub-id pub-id-type="pmid">24516576</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanck</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Buergy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eidinger</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zaman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Krug</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA)</article-title>. <source>Clin. Res. Cardiol.</source> <volume>109</volume> (<issue>11</issue>), <fpage>1319</fpage>&#x2013;<lpage>1332</lpage>. <pub-id pub-id-type="doi">10.1007/s00392-020-01650-9</pub-id>
<pub-id pub-id-type="pmid">32306083</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cha</surname>
<given-names>M.-J.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J.-W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>D.-H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Visualization of left ventricular purkinje fiber distribution using widefield optical coherence microscopy</article-title>. <source>Int. J. Clin. Exp. Pathol.</source> <volume>13</volume> (<issue>12</issue>), <fpage>3013</fpage>&#x2013;<lpage>3020</lpage>.<pub-id pub-id-type="pmid">33425102</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciaccio</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Coromilas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wit</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Garan</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Source-sink mismatch causing functional conduction block in Re-Entrant ventricular tachycardia</article-title>. <source>Jacc Clin. Electrophysiol.</source> <volume>4</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacep.2017.08.019</pub-id>
<pub-id pub-id-type="pmid">29600773</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coronel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Potse</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ha&#xef;ssaguerre</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Derval</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rivaud</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Meijborg</surname>
<given-names>V. M. F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Why ablation of sites with purkinje activation is antiarrhythmic: the interplay between fast activation and arrhythmogenesis</article-title>. <source>Front. Physiol.</source> <volume>12</volume>, <fpage>648396</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2021.648396</pub-id>
<pub-id pub-id-type="pmid">33833689</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costabal</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Hurtado</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Kuhl</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Generating purkinje networks in the human heart</article-title>. <source>J. Biomech.</source> <volume>49</volume> (<issue>12</issue>), <fpage>2455</fpage>&#x2013;<lpage>2465</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiomech.2015.12.025</pub-id>
<pub-id pub-id-type="pmid">26748729</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Almeida</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fontes</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Barra</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guimaraes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Vilhena</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Ungulates heart model: a study of the purkinje network using India ink injection, transparent specimens and computer tomography</article-title>. <source>Anat. Sci. Int.</source> <volume>90</volume> (<issue>4</issue>), <fpage>240</fpage>&#x2013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1007/s12565-014-0255-9</pub-id>
<pub-id pub-id-type="pmid">25316088</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durrer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>van Dam</surname>
<given-names>R. T.</given-names>
</name>
<name>
<surname>Freud</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Janse</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Meijler</surname>
<given-names>F. L.</given-names>
</name>
<name>
<surname>Arzbaecher</surname>
<given-names>R. C.</given-names>
</name>
</person-group> (<year>1970</year>). <article-title>Total excitation of the isolated human heart</article-title>. <source>Circulation</source> <volume>41</volume> (<issue>6</issue>), <fpage>899</fpage>&#x2013;<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.41.6.899</pub-id>
<pub-id pub-id-type="pmid">5482907</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillette</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gsell</surname>
<given-names>M. A. F.</given-names>
</name>
<name>
<surname>Bouyssier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Prassl</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Neic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vigmond</surname>
<given-names>E. J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Automated framework for the inclusion of a his-purkinje system in cardiac digital twins of ventricular electrophysiology</article-title>. <source>Ann. Biomed. Eng.</source> <volume>49</volume> (<issue>12</issue>), <fpage>3143</fpage>&#x2013;<lpage>3153</lpage>. <pub-id pub-id-type="doi">10.1007/s10439-021-02825-9</pub-id>
<pub-id pub-id-type="pmid">34431016</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haissaguerre</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vigmond</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stuyvers</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hocini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bernus</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Ventricular arrhythmias and the his&#x2013;purkinje system</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>13</volume> (<issue>3</issue>), <fpage>155</fpage>&#x2013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1038/nrcardio.2015.193</pub-id>
<pub-id pub-id-type="pmid">26727298</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pogwizd</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Killingsworth</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Noninvasive reconstruction of the three-dimensional ventricular activation sequence during pacing and ventricular tachycardia in the canine heart</article-title>. <source>Am. J. Physiol. - Hear Circ. Physiol.</source> <volume>302</volume> (<issue>1</issue>), <fpage>244</fpage>&#x2013;<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00618.2011</pub-id>
<pub-id pub-id-type="pmid">21984548</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Trew</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Zgierski-Johnston</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cardiac conduction velocity, remodeling and arrhythmogenesis</article-title>. <source>Cells</source> <volume>10</volume> (<issue>11</issue>), <fpage>2923</fpage>. <pub-id pub-id-type="doi">10.3390/cells10112923</pub-id>
<pub-id pub-id-type="pmid">34831145</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ijiri</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ashihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takayama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>A procedural method for modeling the purkinje fibers of the heart</article-title>. <source>J. Physiol. Sci.</source> <volume>58</volume> (<issue>7</issue>), <fpage>481</fpage>&#x2013;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.2170/physiolsci.RP003208</pub-id>
<pub-id pub-id-type="pmid">18926006</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imnadze</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zerm</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Prevention of ventricular fibrillation through de-networking of the purkinje system: proof-Of-concept paper on the substrate modification of the purkinje network</article-title>. <source>PACE - Pacing Clin. Electrophysiol.</source> <volume>42</volume> (<issue>10</issue>), <fpage>1285</fpage>&#x2013;<lpage>1290</lpage>. <pub-id pub-id-type="doi">10.1111/pace.13782</pub-id>
<pub-id pub-id-type="pmid">31424573</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Cherry</surname>
<given-names>E. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Image-based structural modeling of the cardiac purkinje network</article-title>. <source>Biomed. Res. Int.</source> <volume>2015</volume>, <fpage>621034</fpage>. <pub-id pub-id-type="doi">10.1155/2015/621034</pub-id>
<pub-id pub-id-type="pmid">26583120</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Logantha</surname>
<given-names>SJRJ</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X. J.</given-names>
</name>
<name>
<surname>Yanni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>C. B.</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Stuart</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Remodeling of the purkinje network in congestive heart failure in the rabbit</article-title>. <source>Circ. Hear Fail</source> <volume>14</volume> (<issue>7</issue>), <fpage>E007505</fpage>. <pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.120.007505</pub-id>
<pub-id pub-id-type="pmid">34190577</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mages</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gampp</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rahm</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Hackbarth</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Petersenn</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Cardiac stereotactic body radiotherapy to treat malignant ventricular arrhythmias directly affects the cardiomyocyte electrophysiology</article-title>. <source>Hear Rhythm</source> <volume>22</volume> (<issue>1</issue>), <fpage>90</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2024.06.043</pub-id>
<pub-id pub-id-type="pmid">38936449</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Bayer</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Ha&#xef;ssaguerre</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vigmond</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Hocini</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Role of the purkinje-muscle junction on the ventricular repolarization heterogeneity in the healthy and ischemic ovine ventricular myocardium</article-title>. <source>Front. Physiol.</source> <volume>9</volume>, <fpage>718</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2018.00718</pub-id>
<pub-id pub-id-type="pmid">29962961</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Constantin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bernus</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Vigmond</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Bayer</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Wide-area low-energy surface stimulation of large Mammalian ventricular tissue</article-title>. <source>Sci. Rep.</source> <volume>9</volume> (<issue>1</issue>), <fpage>15863</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-51364-w</pub-id>
<pub-id pub-id-type="pmid">31676789</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Bernus</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Vigmond</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Bayer</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Low-energy, single-pulse surface stimulation defibrillates large Mammalian ventricles</article-title>. <source>Hear Rhythm</source> <volume>19</volume> (<issue>2</issue>), <fpage>308</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2021.10.006</pub-id>
<pub-id pub-id-type="pmid">34648972</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myerburg</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>B. F.</given-names>
</name>
</person-group> (<year>1970</year>). <article-title>Electrophysiological propertiesf the canine peripheral A-V conducting system</article-title>. <source>Circ. Res.</source> <volume>26</volume> (<issue>3</issue>), <fpage>361</fpage>&#x2013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.26.3.361</pub-id>
<pub-id pub-id-type="pmid">5415864</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagy</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sz&#xe9;l</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jost</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>T&#xf3;th</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Varr&#xf3;</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Novel experimental results in human cardiac electrophysiology: measurement of the purkinje fibre action potential from the undiseased human heart</article-title>. <source>Can. J. Physiol. Pharmacol.</source> <volume>93</volume> (<issue>9</issue>), <fpage>803</fpage>&#x2013;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2014-0532</pub-id>
<pub-id pub-id-type="pmid">26320996</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okada</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Washio</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kadooka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kariya</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Absence of rapid propagation through the purkinje network as a potential cause of line block in the human heart with left bundle branch block</article-title>. <source>Front. Physiol.</source> <volume>9</volume>, <fpage>56</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2018.00056</pub-id>
<pub-id pub-id-type="pmid">29467667</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ono</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Arakawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Saikawa</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Morphological varieties of the purkinje fiber network in Mammalian hearts, as revealed by light and electron microscopy</article-title>. <source>Arch. Histol. Cytol.</source> <volume>72</volume> (<issue>3</issue>), <fpage>139</fpage>&#x2013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1679/aohc.72.139</pub-id>
<pub-id pub-id-type="pmid">20513977</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Fishman</surname>
<given-names>G. I.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Development and function of the cardiac conduction system in health and disease</article-title>. <source>J. Cardiovasc Dev. Dis.</source> <volume>4</volume> (<issue>2</issue>), <fpage>7</fpage>. <pub-id pub-id-type="doi">10.3390/jcdd4020007</pub-id>
<pub-id pub-id-type="pmid">29098150</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peirlinck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Costabal</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guccione</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Tripathy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Precision medicine in human heart modeling: perspectives, challenges, and opportunities</article-title>. <source>Biomech. Model Mechanobiol.</source> <volume>20</volume> (<issue>3</issue>), <fpage>803</fpage>&#x2013;<lpage>831</lpage>. <pub-id pub-id-type="doi">10.1007/s10237-021-01421-z</pub-id>
<pub-id pub-id-type="pmid">33580313</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sedmera</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gourdie</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Why do we have purkinje fibers deep in our heart?</article-title> <source>Physiol. Res.</source> <volume>63</volume>, <fpage>9</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.33549/physiolres.932686</pub-id>
<pub-id pub-id-type="pmid">24564668</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephenson</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kottas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Perde</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jafarzadeh</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bateman</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>High resolution 3-Dimensional imaging of the human cardiac conduction system from microanatomy to mathematical modeling</article-title>. <source>Sci. Rep.</source> <volume>71</volume> (<issue>1</issue>), <fpage>7188</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-07694-8</pub-id>
<pub-id pub-id-type="pmid">28775383</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Waxman</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Saksena</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Juma</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Sequence of retrograde atrial activation in patients with dual atrioventricular nodal pathways</article-title>. <source>Circulation</source> <volume>64</volume> (<issue>5</issue>), <fpage>1059</fpage>&#x2013;<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.64.5.1059</pub-id>
<pub-id pub-id-type="pmid">7285296</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Tawara</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1906</year>). <source>Das Reizleitungenssystem des S&#xe4;ugetierherzens: eine anatomisch-histologische Studie &#xfc;ber das Atrioventrikularb&#xfc;ndel und die Purkinjeschen F&#xe4;den</source>. <publisher-loc>Germany</publisher-loc>: <publisher-name>Jena, Fischer</publisher-name>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://catalog.nlm.nih.gov/discovery/fulldisplay?vid=01NLM_INST:01NLM_INST&#x0026;docid=alma994380833406676&#x0026;context=L">https://catalog.nlm.nih.gov/discovery/fulldisplay?vid&#x3d;01NLM_INST:01NLM_INST&#x0026;docid&#x3d;alma994380833406676&#x0026;context&#x3d;L</ext-link>
</comment>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tusscher</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Noble</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Noble</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Panfilov</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>A model for human ventricular tissue</article-title>. <volume>286</volume>(<issue>4</issue>):<fpage>1573</fpage>&#x2013;<lpage>1589</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00794.2003</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varshneya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Devenyi</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Sobie</surname>
<given-names>E. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Slow delayed rectifier current protects ventricular myocytes from arrhythmic dynamics across multiple species: a computational study</article-title>. <source>Circ. Arrhythm. Electrophysiol.</source> <volume>11</volume> (<issue>10</issue>), <fpage>e006558</fpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.118.006558</pub-id>
<pub-id pub-id-type="pmid">30354408</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vigmond</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Clements</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Construction of a computer model to investigate sawtooth effects in the purkinje system</article-title>. <source>IEEE Trans. Biomed. Eng.</source> <volume>54</volume> (<issue>3</issue>), <fpage>389</fpage>&#x2013;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1109/TBME.2006.888817</pub-id>
<pub-id pub-id-type="pmid">17355050</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Hocini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ha&#xef;ssaguerre</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Plank</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Influence of the Purkinje-muscle junction on transmural repolarization heterogeneity</article-title>. <source>Cardiovasc Res.</source> <volume>103</volume>, <fpage>629</fpage>&#x2013;<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvu165</pub-id>
<pub-id pub-id-type="pmid">24997066</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Verkerk</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Wilders</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Prakosa</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias</article-title>. <source>Eur. Heart J.</source> <volume>46</volume> (<issue>18</issue>), <fpage>1747</fpage>&#x2013;<lpage>1762</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehaf053</pub-id>
<pub-id pub-id-type="pmid">39973098</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>